This page is part of the Adverse Event Clinical Research (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. The current version which supersedes this version is 1.0.1. For a full list of available versions, see the Directory of published versions
| Page standards status: Informative | 
Generated Narrative: MedicationRequest
Resource MedicationRequest "medicationrequest0301-discontinue"
identifier: id: med0301-studyDrug (use: OFFICIAL)
status: stopped
intent: order
| Reference | 
 
  | 
subject: Patient/ClinicalTrialSubject5 " CLINICAL TRAIL"
authoredOn: 1905-08-23
requester: : Could be reference to inline contained profile such as Reference(practitioner-1) Ronald Bone, MD
| Concept | 
| Psoriasis (SNOMED CT#9014002) | 
| Text | Route | Method | 
| 500mg IV q6h x 3 days | Intravenous route (qualifier value) (SNOMED CT#47625008) | IV Push () | 
Generated Narrative: Medication #med0301
code: Study Medication for psoriasis ()